# OnCo record oncosting (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/oncosting/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "oncosting" ;
  schema:name "OncoSTING"@en ;
  schema:alternateName "OncoSTING LLC"@en, "ONCOSTING LLC"@en ;
  schema:description "OncoSTING is developing OS-151, a modified form of the BCG bladder treatment that also releases a strong immune-activating molecule, for bladder cancer. It is in laboratory testing."@en ;
  schema:url <https://onco.cc/companies/oncosting/>, <https://www.oncosting.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.oncosting.com/>, <https://www.oncosting.com/technology>, <https://reporter.nih.gov/project-details/11312959> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/sting-agonist/>, <https://onco.cc/technologies/bcg-and-intravesical-therapy/> ;
  onco:drugs <https://onco.cc/drugs/os-151/> .